Related Experiment Video
Updated: May 22, 2026

Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation
Published on: December 8, 2017
[The neuroinflammation hypothesis of psychiatric disorders]
1Department of Psychiatry, Faculty of Medicine, Saga University.
Abstract:
The etiology of psychiatric disorders such as depression and schizophrenia remains unclear while, in many aspects, the neuropathology of these disorders has recently been reported to be closely associated with neuroinflammation. Microglia, which are the major players of innate immunity in the CNS, respond rapidly to even minor pathological changes in the brain and may contribute directly to the neuroinflammation by producing various proinflammatory cytokines and free radicals. We and other researchers have recently shown the inhibitory effects of some antidepressants as well as some antipsychotics on the release of inflammatory cytokines and free radicals from activated microglia, both of which have recently been known to cause the synaptic pathology, a decrease in neurogenesis, and white matter abnormalities found in the brains of patients with psychiatric disorders. Microglial activation may not be the primary cause of psychiatric disorders but it may be closely related to the pathology of acute stage of psychiatric disorders. The neuroinflammaiton hypothesis of psychiatric disorders may shed new light on the therapeutic strategy for these disorders.
Insights
Neuroinflammation, involving microglia in the central nervous system (CNS), is linked to psychiatric disorders like depression and schizophrenia. Antidepressants and antipsychotics may reduce neuroinflammation, offering new therapeutic strategies.
Area of Science:
- Neuroscience
- Immunology
- Psychiatry
Context:
- The exact causes of psychiatric disorders, including depression and schizophrenia, are not fully understood.
- Neuropathology in these disorders is increasingly linked to neuroinflammation.
- Microglia, the brain's immune cells, play a key role in the central nervous system's (CNS) inflammatory response.
Purpose:
- To explore the role of microglial activation in the neuropathology of psychiatric disorders.
- To investigate the potential of psychiatric medications in modulating neuroinflammation.
Summary:
- Microglia rapidly respond to brain changes and can exacerbate neuroinflammation by releasing inflammatory cytokines and free radicals.
- Certain antidepressants and antipsychotics have demonstrated inhibitory effects on inflammatory mediators released by activated microglia.
- This neuroinflammation is associated with synaptic pathology, reduced neurogenesis, and white matter abnormalities seen in psychiatric patients.
Impact:
- Microglial activation may be closely associated with the acute stages of psychiatric disorders, rather than being the primary cause.
- The neuroinflammation hypothesis offers novel therapeutic avenues for treating psychiatric conditions.
Related Concept Videos
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Gut-Brain Axis
Encephalitis ll: Pathophysiology
Disorders of the Nervous Tissue
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Bacterial Meningitis II: Pathophysiology
